Very early researchWithdrawnNCT04220892What this trial is testingPilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade GliomaWho this might be right forHigh Grade Glioma Jose Carrillo
Testing effectiveness (Phase 2)Study completedNCT00001493What this trial is testingAntimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast CancerWho this might be right forBreast NeoplasmsNeoplasm Metastasis National Cancer Institute (NCI) 42
Large-scale testing (Phase 3)UnknownNCT03101800What this trial is testingBeneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative ColitisWho this might be right forColitis, UlcerativeColitis Ulcerative Exacerbation Hvidovre University Hospital 84
Large-scale testing (Phase 3)Study completedNCT01701401What this trial is testingSafety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCVWho this might be right forChronic Hepatitis C Virus Gilead Sciences 870
Large-scale testing (Phase 3)Study completedNCT01838590What this trial is testingSofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) InfectionWho this might be right forHepatitis C Virus Gilead Sciences 103
Testing effectiveness (Phase 2)Ended earlyNCT00838578What this trial is testingPhase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal CancerWho this might be right forColorectal Cancer Kyowa Kirin Co., Ltd. 65
Large-scale testing (Phase 3)UnknownNCT01122966What this trial is testingThe Effect of Bevacizumab on the TrabeculectomyWho this might be right forGlaucoma Samsung Medical Center 40
Early research (Phase 1)Study completedNCT00001449What this trial is testingA Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer PatientsWho this might be right forNeoplasms National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00593151What this trial is testingStudy of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis CWho this might be right forHepatitis C Biolex Therapeutics, Inc. 32
Large-scale testing (Phase 3)Study completedNCT01964430What this trial is testingNab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)Who this might be right forPancreatic NeoplasmsDigestive System NeoplasmsNeoplasms by Site+7 more Celgene 866
Post-approval studies (Phase 4)Study completedNCT02177071What this trial is testingA proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination TherapyWho this might be right forCrohn's Disease Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 211
Testing effectiveness (Phase 2)Study completedNCT00001498What this trial is testingA Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast CancerWho this might be right forBreast CancerBreast Neoplasms National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT01808248What this trial is testingSofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3Who this might be right forHepatitis C Gilead Sciences 47
Not applicableApproved For MarketingNCT01779518What this trial is testingExpanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis CWho this might be right forPost-transplant Hepatitis C Gilead Sciences
Large-scale testing (Phase 3)Study completedNCT01091168What this trial is testingTrial of Vinflunine Versus Alkylating Agent in Metastatic Breast CancerWho this might be right forBreast CancerMetastases Pierre Fabre Medicament 594
Large-scale testing (Phase 3)Study completedNCT01232920What this trial is testingFirst-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot TrialWho this might be right forUveitis University of California, San Francisco 80
Early research (Phase 1)Study completedNCT00001764What this trial is testingMycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory ConditionsWho this might be right forVasculitisWegener's Granulomatosis National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT03828019What this trial is testingAdalimumab vs. Conventional Immunosuppression for Uveitis TrialWho this might be right forUveitis JHSPH Center for Clinical Trials 227
Post-approval studies (Phase 4)Study completedNCT01201811What this trial is testingStudy of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)Who this might be right forMyelodysplastic Syndromes Celgene 44
Large-scale testing (Phase 3)Study completedNCT01768286What this trial is testingSafety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV InfectionWho this might be right forChronic Hepatitis C Virus Gilead Sciences 441